Morphotek Inc. Announces a Licensing Deal With Centocor Ortho Biotech Inc. for Exclusive Development and Commercialization Rights for a Therapeutic Monoclonal Antibody
10/28/2009 7:00:42 AM
More...
|
Long-Delayed Centocor Ortho Biotech Inc. Psoriasis Drug Wins U.S. Approval
9/28/2009 7:13:21 AM
More...
|
Centocor Ortho Biotech Inc.'s STELARA(TM) Receives FDA Approval for Treatment of Moderate to Severe Plaque Psoriasis with Four-Times-A-Year Maintenance Dosing
9/25/2009 11:55:22 AM
More...
|
FDA Issues Complete Response Letter For Centocor Ortho Biotech Products, L.P.'s Trabectedin Combined With DOXIL; Agency Requests Additional Information
9/10/2009 11:08:44 AM
More...
|
Tibotec Pharmaceuticals Ltd and Centocor Ortho Biotech Inc. Release: New HIV Study Shows That Large Numbers of Women and People of Color Can Be Successfully Enrolled In U.S. HIV Clinical Studies
7/20/2009 9:42:57 AM
More...
|
Centocor Ortho Biotech Inc. Statement on the FDA ODAC Opinion Regarding DOXIL(R) for Treatment of Advanced Breast Cancer
7/16/2009 8:15:14 AM
More...
|
EU Agency Backs New Centocor Ortho Biotech Inc., Schering-Plough Corporation (SGP) (JOBS) Arthritis Drug
6/26/2009 7:16:40 AM
More...
|
Centocor Ortho Biotech Inc.: Two-Year Data Show Patients Receiving SIMPONI(TM) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
6/10/2009 9:34:29 AM
More...
|
Centocor Ortho Biotech Inc., Schering-Plough Corporation (SGP) (JOBS) Two-Year Data Show Patients Receiving SIMPONI(TM) Experienced Sustained Improvement in Signs and Symptoms of Psoriatic Arthritis and Ankylosing Spondylitis
6/10/2009 7:27:30 AM
More...
|
Centocor Ortho Biotech Inc. New One-Year Data from REMICADE(R) SONIC Trial Show Sustained Efficacy Compared with Azathioprine in Treatment of Crohn's Disease
6/2/2009 11:08:11 AM
More...
|
|